EPISODE · Apr 11, 2025 · 0 MIN
FDA Approves Axsome's New Migraine Drug Symbravo®
from Migraine Minute News Update
The FDA has approved a new drug for the acute treatment of migraine with or without aura in adults. Molly O'Brien has the details and when it becomes available in this Migraine Minute News update. Learn More: https://axsometherapeuticsinc.gcs-web.com/news-releases/news-release-details/axsome-therapeutics-announces-fda-approval-symbravor-meloxicam
NOW PLAYING
FDA Approves Axsome's New Migraine Drug Symbravo®
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m